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	 	 	 Abstract
Cancer is a major disease burden worldwide resulting in high morbidity 
and mortality. It is the leading cause of  mortality in developed countries 
and is one of  the three leading causes of  death for adults in developing 
countries. Pathological examination of  tissue biopsies with histological 
confirmation of  a correct cancer diagnosis is central to cancer care. 
Without an accurate and specific pathologic diagnosis, effective treatment 
cannot be planned or delivered.  In addition, there are marked geographical 
variations in incidence of  cancer overall, and of  the specific cancers 
seen.  Much of  the published literature on cancer incidence in developing 
countries reflects gross estimates and may not reflect reality. Performing 
baseline studies to understand these distributions lays the groundwork for 
further research in this area of  cancer epidemiology. Our current study 
surveys and ranks cancer diagnoses by individual anatomical site at Queen 
Elizabeth Central Hospital (QECH) which is the largest teaching and 
referral hospital in Malawi.  A retrospective study was conducted reviewing 
available pathology reports over a period of  one full year from January 
2010 to December 2010 for biopsies from patients suspected clinically of  
having cancer. There were 544 biopsies of  suspected cancer, taken from 
96 anatomical sites.  The oesophagus was the most common biopsied site 
followed by breast, bladder, bone, prostate, bowel, and cervical lymph 
node. Malignancies were found in biopsies of  the oesophagus biopsies 
(squamous cell carcinoma, 65.1%; adenocarcinoma, 11.6%), breast 
(57.5%), bladder (squamous cell carcinoma, 53.1%) and stomach (37.6%). 
Our study demonstrates that the yield of  biopsy for clinically suspected 
malignancy was greater than 50% for the 11 most common sites and 
provides a current survey of  cancer types by site present in the population 
reporting to our hospital.
Introduction
Histological confirmation by a qualified pathologist is 
central to cancer diagnosis and required to create informed 
cancer treatment plans. Cancer causes a major disease 
burden worldwide with significant associated mortality and 
morbidity. It is the leading cause of  death in developed 
countries and is one of  the three leading causes of  death 
for adults in developing countries1,2.Cancer is currently 
responsible for more than 7 million deaths per year 
worldwide, more than malaria, tuberculosis and HIV/AIDS 
combined1.  In the developing world, the number of  new 
cancer cases will increase significantly over the next 10 
years3. By 2020 there are expected to be 15 million new cases 
of  cancer every year, 70% of  which will be in developing 
countries, where governments are least prepared to address 
the growing cancer burden and where survival rates are often 
less than half  those in more developed countries3. African 
countries will account for over a million new cancer cases a 
year and they are the least able of  all developing countries 
to cope, having fewest cancer care services3. Limitations 
of  resources and basic infrastructure in Malawi result in 
most Malawians having no access to cancer screening, early 
diagnosis, treatment, or palliative care.  In order to improve 
this situation, data on cancer incidence is desperately needed 
to create strategic goals and focused treatment approaches to 
maximize lives saved.
There are over 200 different types of  cancer, but four cancers 
(i.e., lung, breast, prostate, and large bowel) account for more 
than half  of  all cases where data are available 1.  However, there 
are marked geographical variations in incidence of  cancer 
overall and in the specific cancers seen. Such differences 
reflect exposure to distinct causative environmental factors 
such as toxins, infection, and may also represent differences 
in inherited predisposition.  In addition to providing data 
on neoplastic disease, descriptive epidemiology provides the 
basis for prevention, health service planning and allocation 
of  resources.4
In Malawi and many other developing countries there are 
limited studies in the field of  cancer epidemiology and 
cancer in general which impact negatively on the allocation 
of  resources to its management. Few studies have been 
carried out in Africa to determine the variations or ranking 
of  cancer in the specific organ sites leading to the inequitable 
distribution of  resources mostly used to combat the spread 
of  HIV, TB and malaria, which are all acknowledged to be 
major killers in the developing world3. However, in Malawi 
no similar study, according to our knowledge, has been 
conducted.
This study therefore will stand as an initial audit upon 
which large scale epidemiology studies can be based and 
incorporate all cancer types common in the country. It would 
also help allocate appropriate health care resources to cancer 
following increased levels of  understanding of  distribution 
of  different cancer types in particular sites.
The main aim of  this study was to rank current cancer 
diagnoses by individual anatomical site in the year 2010 at 
QECH, which is the largest teaching and referral hospital in 
Malawi.
Additional objectives of  the study were:
1. To determine the yield (% cancer) of  biopsies suspected 
of  malignancy clinically.
2. To determine the distribution of  anatomic sites commonly 
biopsied.




The study was approved by the Institutional ethical board at 
the Malawi College of  Medicine.
Study design and population: We conducted a retrospective 
study at QECH and the College of  Medicine Histopathology 
Laboratory, which is the main pathology laboratory for the 
hospital. The two institutions are next to each other in the 
city of  Blantyre. This study enrolled cases that either had 
excision or incision biopsies from the departments of  surgery, 
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adult oncology and pediatric oncology from January 2010 to 
December 2010 with confirmed histological diagnosis. All 
gynaecological cases were excluded in the study. This was 
because of  frequent use of  cytology and visual inspection 
using acetic acid in our setting and we thought histological 
reports would grossly under-estimate lesions from this site 
relative to other sites. 
Data	collection	and	analysis
The recruited cases and diagnoses from the wards were 
verified at the College of  Medicine Histopathology 
Laboratory. The individual diagnosis and site of  biopsy was 
verified at the pathology department using the laboratory 
reference number. The data was retrospectively collected on 
a standardized structured questionnaire that captured age 
and gender of  patient, site of  biopsy and diagnosis from 
clinical records and pathology records. Data was entered 
and analysed using proportions and frequency tables using 
Microsoft excel and Epiinfo software packages. Frequencies 
of  all biopsied sites were calculated and all diagnoses per 
individual biopsied site, stratified by gender and age were 
ranked.
Study	limitations		
This is a retrospective, hospital based audit, however there 
were no missing set of  records. Since the study is hospital 
based it fails to capture other cases that did not report to our 
hospital from within its catchment area.
Results
There were 544 biopsies that fulfilled our inclusion criteria 
of  the total 1481 specimens sent to COM histopathology 
for histology in 2010. The remaining samples were those 
from other hospitals and gyaenecological biopsies. Of  the 
544, 50% were from males, 49.6% from females, and in 
0.4% gender was unrecorded. The median age was 37 years 
with an interquartile range of  24 to 52 years. There were 
244 cancer diagnoses out of  the 544 biopsies taken which 
represents a yield of  44.9%. The 544 biopsies came from 96 
anatomical sites. The oesophagus was the most common site 
(n=43;8.3%) followed by the breast (n =40; 7.6%), bladder 
(n=32; 6%), bone (n= 32;6%), prostate  (n= 26; 4.9%), large 
bowel (n=18; 3.4%), cervical lymph nodes (n= 16:3%), nose 
(n=16;3%) , stomach (n= 16;3%), skin (n=15;2.8%), liver ( 
n= 8:1.5%). 
Squamous cell carcinoma accounted for 64% of  oesophageal 
biopsies, followed by adenocarcinoma in 11%. The median 
age for patients with adenocarcinoma was 65 years whilst 
that of  squamous cell carcinoma was 45 years. There was a 
female predominance in squamous cell carcinoma with 17 
females and 11 males.
Of  the 40 breast biopsies 47.5% were reported either as 
adenocarcinoma or ductal carcinoma. The age range of  the 
breast cancer cases were 24 to 87 years with a mean of  50.7 
and median of  46 years.  Small numbers of  other related 
malignancies, including fibroadenomas and other benign 
diseases accounted for the rest.
Thirty-two specimens from the bladder were obtained, 
and more than half  (53%) were squamous cell carcinomas, 
9.4% were adenocarcinoma whilst 9.4% were transitional 
cell carcinoma. The median age for the squamous cell 
carcinoma was 47 years and the majority was female (67.4%). 
Transitional cell carcinoma median age was 16 years whilst 
adenocarcinoma was 50 years. 
The stomach site had 16 specimens reported, the majority 
of  the cases 9 (56.3%) were benign, 5 (31.3%) were 
adenocarcinoma. The median age of  the five patients with 
malignancy was 68 years. 
More than half  of  the 15 cervical lymph node biopsies 
were malignant. Three were Kaposi’s sarcoma (median 
age of  30years), and 2 (13.3%) were reported as invasive 
squamous cell carcinoma. The squamous cell carcinoma 
group had a median age of  48 years. Other diagnoses were 
2 non-Hodgkin’s lymphoma (13.4%) and 1 (6.7%) metastatic 
carcinoma, with unspecified histology.
In the prostate 2 (7.7%) were adenocarcinoma and the rest 
24 (92.3%) showed benign prostate hypertrophy (BPH).
Of  the 8 liver biopsies, 4 were hepatocellular carcinoma, 
1 was an  adenocarcinoma (median age of  38 years) and 
one hepatoblastoma was reported from a 9 year old.  The 
remaining 25% percent of  the biopsies of  the liver were 
non-malignant (Figure 2).
Discussion	
The most commonly biopsied sites had oesophagus, 
bladder and liver yielding cancer diagnoses in over 75% of  
biopsies. The breast cancer yield of  57.5% demonstrates 
that a suspicious breast mass or lesions is  likely to be 
cancerous.  Overall, these findings highlight the importance 
of  histological confirmation as a requirement for treatment 
since cancer is common and varied.
Cancer of  the prostate is the fifth most common cancer 
in the world and the second most common in men5. The 
relative low yield of  prostatic cancer in our study can be 
explained by the younger age of  our patients (average 65 
years) who had prostate biopsies compared to other studies. 
The average age was 67 years in the SEER data of  2004 to 
2008 and 73 years in SEER-Medicare data of  1991 to 20076,7. 
The ranking (5th) of  this cancer in the National Cancer 
Registry is low.  However, a report from Zimbabwe indicates 
prostate cancer as the commonest cancer in males.[12] The 
majority of  the cases in our study (92.3%) were benign 
prostate hypertrophy. Another reason for the low cancer 
yield in this group may reflect the fact that there was no pre-
biopsy PSA determination.  The rate of  invasive prostatic 
adenocarcinoma was 58.2% in a study where the average 
pre-biopsy PSA level was 8.7µg/L.8  Our data may suggest 
prostate cancer is missed or misdiagnosed.
The relatively low yields of  cancer from the gastrointestinal 
tract - stomach 37.6% and large bowel 44.4% - may be 
explained by frequent occurrence of  other benign lesions 
in these sites such as ulceration and polyps respectively. 
However these yields are still high enough to argue for a high 
index of  suspicion for cancer and biopsy in these sites.
The oesophagus was the most commonly biopsied site. This 
is not surprising, considering it is the second reported cancer 
in males and third in Malawi if  both sexes are considered 
according to the National Cancer Registry (NCR)9.  The 
most common histological diagnosis on this site was 
squamous cell carcinoma (65.1%) which is consistent with 
the global findings but opposite to Western trends where 
adenocarcinomas predominate[5]. This underlies the 
fact that Barrett’s esophagus is not the main risk factor in 
Malawian cases of  oesophageal cancer. The predominance 
of  squamous histology suggests that smoking, alcohol and 
aflatoxin B may be important aetiological factors.  
In Malawi Kaposi sarcoma is thought to be the most common 
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malignancy in adults, but in this study, skin is not the most 
biopsies were not taken commonly. This may be because it 
is assumed  that clinical diagnoses of   Kaposi sarcoma are 
made. Apart from these two cancers other malginanices are 
likely to get biopsied due to difficulty in making a definite 
diagnosis clinically. For this reason, we believe the data for 
the cancers other than Kaposi sarcoma and skin do represent 
the distribution of  cancers that present at our hospital.  
Cervical cancer is the commonest cancer in females and 
the second most frequent when both sexes are combined 
(NCR)9. However, our study did not include gynaecologic 
cancers.   
Breast cancer is by far the most frequent cancer of  women 
in the world ranking second overall when both sexes are 
considered together, and fifth in women according to the 
Malawi National Cancer Registry5,9.  The ease in tissue 
procurement, as well as the difficulty in distinguishing benign 
from malignant breast disease contributes to the frequency 
of  these biopsies.
Bladder biopsies had a high yield of  squamous cell 
carcinoma histology (53.1%) which is different from the 
findings in developed countries where transitional cell 
carcinoma as the most common histology. This finding is 
consistent with reports from  neighbouring countries where 
squamous cell carcinoma predominates. A study in north 
west Tanzania reported squamous cell carcinoma histology 
in 55.1% of  cases. These were found to be associated with 
schistosomiasis compared to the non squamous cancers.13It 
has been suggested that such high prevalence of  squamous 
cell carcinoma in parts of  Africa is linked to chronic infection 
with Schistosoma hematobium.5
Samples from the 15 cervical node biopsies yielded cancers 
in 53.4% but infections represented only 33.3%. The most 
common cancer was Kaposi’s sarcoma, unlike the squamous 
cell carcinoma reported in Western literature. This may 
be due to the high HIV prevalence in Malawi and argues 
strongly against the practice of  diagnosing TB clinically 
based on the repsence of  enlarged nodes without taking a 
biopsy. Our data shows that the occurrence of  malignancies 
at this site is not rare.
Conclusion	and	recommendations
Our study demonstrated that the yield of  malignancy in 
most of  the sites clinically suspected to have cancer was very 
high and gives histological ranking for different biopsied 
sites. This supports the practice of  using histology as a 
gold standard to diagnose cancer.  The histological trends 
as well as the findings of  malignancy rather than TB in 
cervical lymph nodes re-enforces this. It also demonstrates 
differences in prevalence of  cancer histology in particular 
sites which suggests differences in risk factors between our 
Centre, located in Sub-Saharan Africa, and the West.10,11 
More studies on cancer epidemiology in this region should 
be encouraged to fully understand the incidence and risk 
factors for the different cancers in Sub-Saharan Africa.
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